Search - tctmd.com

Displaying 241 - 260 of 1707

Sort: Relevancy | Date

Presentation NY Valves 2024

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

Presenter: Omar K. Khalique

June 07, 2024

Presentation NY Valves 2024

Device-Related Thrombus Post-LAAO: Diagnosis, Prevention, & Management

Presenter: Amit N. Vora

June 07, 2024

Presentation NY Valves 2024

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Presenter: Brian R. Lindman

June 07, 2024

Presentation NY Valves 2024

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Presenter: Scott M. Chadderdon

June 06, 2024

Presentation NY Valves 2024

Case 2: TAVR in MAC With Lampoon and Sapien – Step-by-step Approach and Clinical Outcomes

Presenter: Adam B. Greenbaum

June 06, 2024

Presentation NY Valves 2024

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

Presenter: Jason H. Rogers

June 06, 2024

Presentation NY Valves 2024

Pro-Surgery

Presenter: James M. McCabe

June 06, 2024

Presentation NY Valves 2024

Pro-TMVR

Presenter: Tsuyoshi Kaneko

June 06, 2024

Presentation NY Valves 2024

What Is MAC? Incidence, Diagnosis, Grading, and Clinical Relevance: 2024 Updates

Presenter: Mackram F. Eleid

June 06, 2024

Presentation NY Valves 2024

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

Presenter: Vinayak N. Bapat

June 06, 2024

Presentation NY Valves 2024

The CT Imaging Diagnosis of Bicuspid Aortic Stenosis

Presenter: Hasan Jilaihawi

June 05, 2024

Presentation NY Valves 2024

Atrial FMR; Diagnosis and Therapy Choices (Including AF ablation)

Presenter: Jörg Hausleiter

June 05, 2024

Presentation NY Valves 2024

Revolutionizing Valvular Disease Diagnosis: Empowering Non-Cardiology Practitioners With AI-Augmented POCUS

Presenter: Elad Maor

June 05, 2024

Presentation NY Valves 2024

TR: Diagnosis, Severity, Risk Stratification, and Management Based on Imaging

Presenter: Fabien Praz

June 05, 2024

Presentation NY Valves 2024

Moderate AS: Diagnosis, Risk Stratification, Current Management, and Ongoing Trials

Presenter: Philippe Pibarot

June 05, 2024

Presentation NY Valves 2024

Mitral Regurgitation Quantitation: Are Different Methods Required for Primary vs Secondary Disease?

Presenter: Paul A. Grayburn

June 05, 2024

Presentation NY Valves 2024

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

Presenter: Anjali Sharma

June 05, 2024

Presentation NY Valves 2024

Paradoxical Low-Flow, Low-Gradient AS: Diagnosis and Management based on Multi-Modality Imaging

Presenter: Marie-Annick Clavel

June 05, 2024

News Daily News

HF Severity, Outcomes Tied to Markers of Neurodegeneration

Todd Neale

June 04, 2024

News Daily News

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Caitlin E. Cox

May 29, 2024

Advertisement

How Can We Improve the Diagnosis of Significant AR? The Case for Multi-Modality Imaging!

Device-Related Thrombus Post-LAAO: Diagnosis, Prevention, & Management

Impact of Delays in Diagnosis and Treatment: Introducing the TARGET AS Program

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Case 2: TAVR in MAC With Lampoon and Sapien – Step-by-step Approach and Clinical Outcomes

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

Pro-Surgery

Pro-TMVR

What Is MAC? Incidence, Diagnosis, Grading, and Clinical Relevance: 2024 Updates

Introduction to the Redo TAVR App: Comprehensive Diagnosis and Procedure Planning

The CT Imaging Diagnosis of Bicuspid Aortic Stenosis

Atrial FMR; Diagnosis and Therapy Choices (Including AF ablation)

Revolutionizing Valvular Disease Diagnosis: Empowering Non-Cardiology Practitioners With AI-Augmented POCUS

TR: Diagnosis, Severity, Risk Stratification, and Management Based on Imaging

Moderate AS: Diagnosis, Risk Stratification, Current Management, and Ongoing Trials

Mitral Regurgitation Quantitation: Are Different Methods Required for Primary vs Secondary Disease?

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

Paradoxical Low-Flow, Low-Gradient AS: Diagnosis and Management based on Multi-Modality Imaging

HF Severity, Outcomes Tied to Markers of Neurodegeneration

With ANOCA, Better to Test Coronary Function in Multiple Vessels

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content